BioMarin Pharmaceutical, Inc. (BMRN)

56.08 +0.88 (+1.59%) USD  |  NASDAQ  |  Jan 14, 16:00
56.10 +0.02 (+0.03%) After-Hours: 20:00
More

BioMarin Pharmaceutical Total Expenses (% of Annual Revenues)

Total Expenses (% of Annual Revenues) Chart

View Total Expenses (% of Annual Revenues) for BMRN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (% of Annual Revenues) Range, Past 5 Years

View Total Expenses (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Annual Revenues) Benchmarks

View Total Expenses (% of Annual Revenues) Benchmarks
Start Trial
Amicus Therapeutics, Inc. Upgrade
Gilead Sciences, Inc. Upgrade
Merck & Co., Inc. Upgrade
AbbVie, Inc. Upgrade
Bristol Myers Squibb Co. Upgrade